New brain stent aims to stop repeat strokes in High-Risk patients

NCT ID NCT07197970

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 33 times

Summary

This study tests a new drug-coated stent (NxiDIME) for people with severely narrowed brain arteries who have already had a stroke or mini-stroke. About 224 participants will be randomly assigned to get either the new stent or a similar approved stent. The goal is to see if the new stent better prevents the artery from narrowing again over 12 months, which could reduce the risk of future strokes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYMPTOMATIC INTRACRANIAL ATHEROSCLEROTIC STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • A prospective, multi-center, randomized controlled, non-inferiority clinical trial to evaluate the safety and efficacy of the NxiDIME™ Intracranial Drug-Eluting Stent System in the treatment of symptomatic intracranial atherosclerotic stenosis lesions

    RECRUITING

    Beijing, Beijing Municipality, 100000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.